CN1118141A - 结合使用可溶性补体受体-1(scr1)和脒基苯基或脒基萘基酯治疗炎症 - Google Patents

结合使用可溶性补体受体-1(scr1)和脒基苯基或脒基萘基酯治疗炎症 Download PDF

Info

Publication number
CN1118141A
CN1118141A CN94191260A CN94191260A CN1118141A CN 1118141 A CN1118141 A CN 1118141A CN 94191260 A CN94191260 A CN 94191260A CN 94191260 A CN94191260 A CN 94191260A CN 1118141 A CN1118141 A CN 1118141A
Authority
CN
China
Prior art keywords
apan
brl55730
amidinophenyl
ester
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN94191260A
Other languages
English (en)
Chinese (zh)
Inventor
D·E·I·莫沙考斯卡
R·A·G·史密夫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of CN1118141A publication Critical patent/CN1118141A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN94191260A 1993-01-22 1994-01-21 结合使用可溶性补体受体-1(scr1)和脒基苯基或脒基萘基酯治疗炎症 Pending CN1118141A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9301289.6 1993-01-22
GB939301289A GB9301289D0 (en) 1993-01-22 1993-01-22 Novel composition

Publications (1)

Publication Number Publication Date
CN1118141A true CN1118141A (zh) 1996-03-06

Family

ID=10729169

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94191260A Pending CN1118141A (zh) 1993-01-22 1994-01-21 结合使用可溶性补体受体-1(scr1)和脒基苯基或脒基萘基酯治疗炎症

Country Status (10)

Country Link
EP (1) EP0680332A1 (enExample)
JP (1) JPH08505867A (enExample)
CN (1) CN1118141A (enExample)
AU (1) AU5863694A (enExample)
CA (1) CA2153797A1 (enExample)
GB (1) GB9301289D0 (enExample)
NZ (1) NZ259737A (enExample)
TW (1) TW241203B (enExample)
WO (1) WO1994016719A1 (enExample)
ZA (1) ZA94398B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0724435T3 (da) * 1993-10-21 2002-11-25 Searle & Co Amidinoderivater, der er nyttige som nitrogenoxid-synthase-inhibitorer
GB9604518D0 (en) * 1996-03-02 1996-05-01 Smithkline Beecham Plc Novel compounds
US8088386B2 (en) * 1998-03-20 2012-01-03 Genentech, Inc. Treatment of complement-associated disorders
JP4897690B2 (ja) * 2004-10-12 2012-03-14 ジェネンテック， インコーポレイテッド 補体関連障害の予防および処置のためのＣＲＩｇポリペプチド
GB201800620D0 (en) 2018-01-15 2018-02-28 Univ Manchester C3b Binding Polypeptide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ191320A (en) * 1978-09-07 1982-09-14 Beecham Group Ltd In vivo fibrinolytic enzyme having active site blocked by hydrolytically removable group pharmaceutical compositions
GB2095239B (en) * 1981-02-27 1985-03-06 Torii & Co Ltd Novel amidine compounds
JPS57179147A (en) * 1981-04-28 1982-11-04 Torii Yakuhin Kk Amidine derivative
US5256642A (en) * 1988-04-01 1993-10-26 The Johns Hopkins University Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof
WO1992010205A1 (en) * 1990-12-06 1992-06-25 T Cell Sciences, Inc. Synergistic compositions of soluble complement receptors and compounds that inhibit complement and/or suppress immune activity

Also Published As

Publication number Publication date
CA2153797A1 (en) 1994-08-04
WO1994016719A1 (en) 1994-08-04
AU5863694A (en) 1994-08-15
TW241203B (enExample) 1995-02-21
GB9301289D0 (en) 1993-03-17
ZA94398B (en) 1994-11-15
NZ259737A (en) 1997-04-24
JPH08505867A (ja) 1996-06-25
EP0680332A1 (en) 1995-11-08

Similar Documents

Publication Publication Date Title
JP3277147B2 (ja) グリコーゲン・ホスホリラーゼインヒビターを用いる、非−心虚血と関連する組織損傷の軽減方法
US7241783B2 (en) Thrombopoietin mimetics
US10160736B2 (en) 1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives as immunomodulators
CN113166060B (zh) 用丙酮酸激酶激活化合物治疗镰状细胞病
EP0486809A2 (en) Use of suramin against TNF-related diseases
CN1318056A (zh) 用于治疗衰老相关性疾病和糖尿病性血管性并发症的新化合物,其制备方法,及其治疗用途
JP2008528634A (ja) 腫瘍壊死因子インヒビター
EP0560929A1 (en) Synergistic compositions of soluble complement receptors and compounds that inhibit complement and/or suppress immune activity
US8283344B2 (en) Method of treating inherited severe neutropenia
CN1118141A (zh) 结合使用可溶性补体受体-1(scr1)和脒基苯基或脒基萘基酯治疗炎症
TWI664174B (zh) 雜環化合物及其用途
US20120020923A1 (en) Method of treating viral diseases with combinations of TPO receptor agonist and anti-viral agents
WO2025157284A1 (zh) 包含prmt5抑制剂和化疗剂的药物组合物
CN1102391C (zh) 结晶状的药用产物
CN1859846A (zh) 白屈菜赤碱、其类似物及其在治疗躁郁症和其他认知紊乱中的应用
US20240325382A1 (en) Compositions and methods for treating anemia associated with a ribosomal disorder
JP2004520396A (ja) 過剰な又は不十分な細胞死によって特徴づけられる疾患の治療
CN1490329A (zh) 咪唑啉取代的苯氧乙酰寡肽类衍生物，它们的合成及在医学中的应用
AU2011291398A1 (en) Antifungal agents and uses thereof
KR102190019B1 (ko) 쇼그렌 증후군 예방 또는 치료용 조성물
Al-Odat Selective Small Molecule Targeting of MCL-1 in Multiple Myeloma
JPH0565487B2 (enExample)
JPH11509205A (ja) Ｎ，ｎ−ジメチル−８，８−ジプロピル−２−アザスピロ〔４．５〕デカン−２−プロパンアミン・ジマレエート
US20100016358A1 (en) Gamma-globin inducer
US20030216324A1 (en) Airway mucus secretion inhibitors

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication